Answers are grounded in this paper and cite their sources.
Preparations of 5-ASA are the first line treatment of ulcerative colitis (UC). Today, in the market of drugs 5-ASA available for the treatment of UC, there are many dosage forms, varying in the coating, method of delivery of active substance and dosing regimens of the drug. The aim of this review is to compare these dosage forms by the main parameters: efficiency, safety and adherence to treatment.
No takes yet. Share an insight, caveat, or question.
Шапина et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: